Overview
DOCS market data
Price History
DOCS price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for DOCS. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
'Telehealth Firms Urge FDA to Legalize Peptides, With Guardrails' - BloombergBenzinga · Jul 23, 2026, 2:14 PM
Doximity Announces Doximity Ask Came Ahead Of Frontier AI Models In Numerous Options Harm Assessment For Risk In Medicine BenchmarkBenzinga · Jul 15, 2026, 6:27 PM
Doximity's AI Expansion Raises Execution Risks: AnalystBenzinga · Jun 29, 2026, 5:50 PM
This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For MondayBenzinga · Jun 29, 2026, 12:50 PM
B of A Securities Downgrades Doximity to Underperform, Lowers Price Target to $20Benzinga · Jun 29, 2026, 11:05 AM
Benzinga Bulls And Bears: Nvidia, Cisco, Virgin Galactic — And Inflation Fears Rattle InvestorsBenzinga · May 16, 2026, 12:51 PM
Nasdaq 100 Drops, Intel Crashes 7% On Rate-Hike Panic: Stock Market TodayBenzinga · May 15, 2026, 5:49 PM
Goldman Sachs Maintains Neutral on Doximity, Lowers Price Target to $24Benzinga · May 15, 2026, 3:35 PM
Gemini Space Posts Upbeat Q1 Results, Joins Figma, Sutro Biopharma And Other Big Stocks Moving Higher On FridayBenzinga · May 15, 2026, 2:15 PM
Barclays Downgrades Doximity to Equal-Weight, Lowers Price Target to $20Benzinga · May 15, 2026, 12:45 PM